Developed for surgeons by surgeons, and led by a team of technologically seasoned entrepreneurs, OpLogix understands the frustrations associated with healthcare delivery and technology and wants to partner with you for success.

Dr. Steven Haas

Dr. Steven Haas, a world-renowned leader in orthopedic surgery, is Chief of the Knee Service at Hospital for Special Surgery. In addition, Dr. Haas is the co-chair of Hospital for Special Surgery’s Quality Coordinating Committee, which develops and monitors quality assurance activities at the hospital. This unique combination led to the concept of OrthoSecure©.

Dr. Haas developed a groundbreaking surgical technique and instrumentation for performing Minimally Invasive Knee Replacement, for which he was awarded a US Patent in September 2009. He has been featured as a developer and expert on Minimally Invasive Total Knee Replacement on WNBC News and NY1 News, and in Runner magazine, the New York Daily News, and the Cleveland Clinic Newsletter.

In June of 2009, Dr. Haas performed a Minimally Invasive Knee Replacement Surgery that was broadcast live via webcast and also covered by WCBS News via their Twitter feed. In July of 2007, Dr. Haas and his Minimally Invasive Knee Replacements were featured in a U.S. News & World Report photo essay “To Build a Knee.”

In October 2007, CBS News with Katie Couric featured a segment focusing on Dr. Haas that discussed High Performance Knee Replacement. Additionally, Dr. Haas has appeared on WABC News and in U.S. News & World Report as an expert on Gender Knee Replacement.

Dr. Haas holds three United States patents for orthopedic devices and co-developed the iOS app for Hospital for Special Surgery. He speaks nationally and internationally on knee and hip topics, and has more than 60 publications in orthopedic literature.

Dr. Haas received his education and training at Harvard University, Cornell University and University of Rochester, and is affiliated with the Knee Society, American Academy of Orthopedic Surgeons and American Association of Hip and Knee Surgeons.


  • Chief of Knee Service, Hospital for Special Surgery
  • John N. Insall Chair, Knee Surgery
  • Attending Orthopedic Surgeon, Hospital for Special Surgery
  • Professor of Orthopedic Surgery, Weill Cornell Medical College


  • “Best Doctors in New York,” New York magazine, 2009, 2010, 2011, 2012, 2013
  • “America’s Top Doctors,”  Castle Connolly, 2007, 2008, 2009, 2010, 2011, 2012, 2013
  • 2010 Health Network Service Excellence Award
  • Phi Beta Kappa
  • Alpha Omega Alpha, National Honor Medical Society
  • Lewis Clark Wagner Research Award for Best Research Paper by a Resident, 1989

Michael Roe

Michael Roe has a 23-year record of success and innovation in high-growth software and IT industries. He is the founder, and former chairman and CEO of NaviSys, a leading insurance software and consulting firm acquired by Accenture in 2006. Mr. Roe led NaviSys for 15 years, where he focused on providing innovative solutions that increased business performance through all phases of the business cycle.

Michael speaks at insurance conferences and has been published in Best’s Review and LOMA Resource.

Mr. Roe graduated from Rutgers College in 1985 with a B.A in Computer Science and is a Board Member of FAST Technology and FirstBest Systems.

Matthew Perron

Matthew Perron has spent his entire professional career involved in consulting, selling and servicing total joint, arthroscopy and orthopedic trauma products.

Over the course of his career, Mr. Perron has seen sweeping changes in how the orthopedic device industry interacts with providers. Having spent 10 years “standing in an operating room,” Mr. Perron has gained firsthand knowledge and insight into the many flaws and potential risks associated with implant surgery.

Prior to joining OpLogix, Mr. Perron spent eight years with Depuy Orthopedics, a Johnson & Johnson company. Highlighting his time at Depuy, Mr. Perron was recognized for having one of the country’s top trauma territories. As a result, he was chosen as one of a select few people in the country to begin a pilot program selling both Depuy total joint implants and Synthes trauma products (J&J acquired Synthes Inc. in 2012).

Mr. Perron is a 2007 graduate of the College of the Holy Cross, where he received a B.A in both Economics and Religious Studies.